- North America
- United States
- Human Medicines, Biopharmaceuticals, …
- Service category
- eData - IT - software, Consulting - strategy and development
Your company? Get access to this profile.
We are best known for our strength in the prediction of outcomes for all steps on the path to drug commercialization, from discovery to completion of Phase III and post-marketing trials. But not only do our platforms model pharmaceutical therapies, they also model consumer products, foods, and cosmetics for human and veterinary applications. Modeling is a means of non-invasive research.
For over 15 years, the company has been enhancing its in silico modeling software and platforms created by our teams of scientists, mathematical modelers, and programmers. Our platforms represent years of careful calibration and validation using actual clinical and peer-reviewed public data. Our Virtual Patients and Virtual Populations enhance predictions for all phases of discovery and clinical trials. The result is better understanding of patient variation, better target identification, more efficient trial design and biomarker analysis – providing more options when development seems cumbersome or blocked. The beneficiaries of our modeling efforts include the FDA and many major pharmaceutical and consumer product companies.
You might also be interested in
Sourcing this company's services?Send inquiry anonymously »